Jakub Marczak
Research Subjects
Jakub Marczak has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Romuald Cichon
Department of Cardiac Surgery, Warsaw Medical University, Warsaw, Poland
8 shared publicationsSleiman Sebastian Aboul-Hassan
8 shared publicationsTomasz Stankowski
Department of Cardiac Surgery, Sana-Heart Center Cottbus, Cottbus, Germany
6 shared publicationsRomuald Cichoń
Department of Cardiac Surgery, Warsaw Medical University, Warsaw, Poland, Poland
5 shared publications- Tomasz Stankowski
Sana Heart Ctr Cottbus, Dept Cardiac Surg, Cottbus, Germany
5 shared publications Anna Szymańska
Heart Diseases Center MEDINET, Nowa Sol, Poland, Poland
4 shared publications
Latest Publications
- 10 April 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (4) , 750-754
Surgical closure of patent ductus arteriosus in extremely low birth weight infants weighing less than 750 grams
Background: Patent ductus arteriosus (PDA) occurs more frequently in premature infants. Depending on the degree of prematurity, these children often have other serious comorbidities that could significantly impact on surgical outcome. Aim: This study aimed to evaluate clinical results of the surgical ligation of PDA in extremely low body weight preterm infants with birth weight below 750 grams and to identify risk factors of mortality. Methods: A total of 31 preterm infants with birth weight below 750 grams and significant PDA were operated between 2006 and 2016 through posterolateral thoracotomy (n=16) or with the use of video-assisted thoracoscopic (VATS) method (n = 15). Mean weight at the time of surgery was 750.8 ± 104.7 g. The gestational age ranged from 22 to 32 weeks. Data were retrospectivel1y analyzed and prospective 100% follow-up was performed. Results: In-hospital mortality was 25.8% (n = 8). Type of surgery had no influence on the results. During the follow-up period lasting 5.2 ± 2.5 years two other patients died. One-year and 5-year probability of survival was 77.4% and 74.2%, respectively. The predominant cause of death was acute heart failure. All patients with preoperative renal dysfunction died in the postoperative period. Moreover, Cox regression analysis revealed renal dysfunction as an independent risk factor of early death. Conclusions: Preterm infants with birth weight less than 750 grams and significant PDA are highly challenging patients. Despite the recent advances in perioperative management with neonates, surgery is still associated with high early mortality rate irrespective of applied method. Background: Patent ductus arteriosus (PDA) occurs more frequently in premature infants. Depending on the degree of prematurity, these children often have other serious comorbidities that could significantly impact on surgical outcome. Aim: This study aimed to evaluate clinical results of the surgical ligation of PDA in extremely low body weight preterm infants with birth weight below 750 grams and to identify risk factors of mortality. Methods: A total of 31 preterm infants with birth weight below 750 grams and significant PDA were operated between 2006 and 2016 through posterolateral thoracotomy (n=16) or with the use of video-assisted thoracoscopic (VATS) method (n = 15). Mean weight at the time of surgery was 750.8 ± 104.7 g. The gestational age ranged from 22 to 32 weeks. Data were retrospectivel1y analyzed and prospective 100% follow-up was performed. Results: In-hospital mortality was 25.8% (n = 8). Type of surgery had no influence on the results. During the follow-up period lasting 5.2 ± 2.5 years two other patients died. One-year and 5-year probability of survival was 77.4% and 74.2%, respectively. The predominant cause of death was acute heart failure. All patients with preoperative renal dysfunction died in the postoperative period. Moreover, Cox regression analysis revealed renal dysfunction as an independent risk factor of early death. Conclusions: Preterm infants with birth weight less than 750 grams and significant PDA are highly challenging patients. Despite the recent advances in perioperative management with neonates, surgery is still associated with high early mortality rate irrespective of applied method.
- 10 April 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (4) , 750-754
Surgical closure of patent ductus arteriosus in extremely low birth weight infants weighing less than 750 grams
Background: Patent ductus arteriosus (PDA) occurs more frequently in premature infants. Depending on the degree of prematurity, these children often have other serious comorbidities that could significantly impact on surgical outcome. Aim: This study aimed to evaluate clinical results of the surgical ligation of PDA in extremely low body weight preterm infants with birth weight below 750 grams and to identify risk factors of mortality. Methods: A total of 31 preterm infants with birth weight below 750 grams and significant PDA were operated between 2006 and 2016 through posterolateral thoracotomy (n=16) or with the use of video-assisted thoracoscopic (VATS) method (n = 15). Mean weight at the time of surgery was 750.8 ± 104.7 g. The gestational age ranged from 22 to 32 weeks. Data were retrospectivel1y analyzed and prospective 100% follow-up was performed. Results: In-hospital mortality was 25.8% (n = 8). Type of surgery had no influence on the results. During the follow-up period lasting 5.2 ± 2.5 years two other patients died. One-year and 5-year probability of survival was 77.4% and 74.2%, respectively. The predominant cause of death was acute heart failure. All patients with preoperative renal dysfunction died in the postoperative period. Moreover, Cox regression analysis revealed renal dysfunction as an independent risk factor of early death. Conclusions: Preterm infants with birth weight less than 750 grams and significant PDA are highly challenging patients. Despite the recent advances in perioperative management with neonates, surgery is still associated with high early mortality rate irrespective of applied method. Background: Patent ductus arteriosus (PDA) occurs more frequently in premature infants. Depending on the degree of prematurity, these children often have other serious comorbidities that could significantly impact on surgical outcome. Aim: This study aimed to evaluate clinical results of the surgical ligation of PDA in extremely low body weight preterm infants with birth weight below 750 grams and to identify risk factors of mortality. Methods: A total of 31 preterm infants with birth weight below 750 grams and significant PDA were operated between 2006 and 2016 through posterolateral thoracotomy (n=16) or with the use of video-assisted thoracoscopic (VATS) method (n = 15). Mean weight at the time of surgery was 750.8 ± 104.7 g. The gestational age ranged from 22 to 32 weeks. Data were retrospectivel1y analyzed and prospective 100% follow-up was performed. Results: In-hospital mortality was 25.8% (n = 8). Type of surgery had no influence on the results. During the follow-up period lasting 5.2 ± 2.5 years two other patients died. One-year and 5-year probability of survival was 77.4% and 74.2%, respectively. The predominant cause of death was acute heart failure. All patients with preoperative renal dysfunction died in the postoperative period. Moreover, Cox regression analysis revealed renal dysfunction as an independent risk factor of early death. Conclusions: Preterm infants with birth weight less than 750 grams and significant PDA are highly challenging patients. Despite the recent advances in perioperative management with neonates, surgery is still associated with high early mortality rate irrespective of applied method.
- Open Access
- 5 April 2018
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 27 (4) , 548-554
Is administration of dual-antiplatelet therapy beneficial for patients following off-pump coronary artery bypass grafting?
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether administration of dual-antiplatelet therapy (DAPT) following off-pump coronary artery bypass grafting (OPCAB) would improve postoperative clinical outcomes or minimize the incidence of postoperative graft failure. In total, 101 papers were found using the reported search, 14 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. One meta-analysis and 3 randomized controlled trials showed that DAPT following OPCAB is associated with decreased incidence of saphenous vein graft occlusion. One randomized controlled trial and 4 observational studies showed no effect of DAPT on mortality following OPCAB, whereas 3 observational studies showed that DAPT decreased mortality. One meta-analysis and 4 observational studies showed that DAPT reduced the incidence of cardiac events following OPCAB. One randomized controlled trial and 4 observational studies showed that DAPT did not increase the incidence of major or minor bleeding complications following OPCAB. The results presented suggest that administration of DAPT in patients following OPCAB for at least 3 months improves saphenous vein graft patency and could be protective against recurrence of cardiac events, especially acute coronary syndrome, in comparison with aspirin monotherapy. The administration of DAPT following OPCAB is safe and is not associated with increased incidence of major or minor bleeding complications when compared with aspirin alone.
- 5 April 2018
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 27 (4) , 548-554
Open AccessIs administration of dual-antiplatelet therapy beneficial for patients following off-pump coronary artery bypass grafting?
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether administration of dual-antiplatelet therapy (DAPT) following off-pump coronary artery bypass grafting (OPCAB) would improve postoperative clinical outcomes or minimize the incidence of postoperative graft failure. In total, 101 papers were found using the reported search, 14 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. One meta-analysis and 3 randomized controlled trials showed that DAPT following OPCAB is associated with decreased incidence of saphenous vein graft occlusion. One randomized controlled trial and 4 observational studies showed no effect of DAPT on mortality following OPCAB, whereas 3 observational studies showed that DAPT decreased mortality. One meta-analysis and 4 observational studies showed that DAPT reduced the incidence of cardiac events following OPCAB. One randomized controlled trial and 4 observational studies showed that DAPT did not increase the incidence of major or minor bleeding complications following OPCAB. The results presented suggest that administration of DAPT in patients following OPCAB for at least 3 months improves saphenous vein graft patency and could be protective against recurrence of cardiac events, especially acute coronary syndrome, in comparison with aspirin monotherapy. The administration of DAPT following OPCAB is safe and is not associated with increased incidence of major or minor bleeding complications when compared with aspirin alone.
- 22 January 2018
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 26 (6) , 1027-1034
Does patient–prosthesis mismatch have a negative impact on outcomes following mitral valve replacement?
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether patient-prosthesis mismatch (PPM) has a negative impact on patients undergoing mitral valve replacement in terms of postoperative mortality, incidence of postoperative pulmonary hypertension (PH) and higher transmitral gradients. Altogether 103 papers were found using the reported search, 18 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Overall, 8 studies with a total of 4812 patients reported that PPM has a significantly negative impact on long-term mortality, whereas 5 studies with a total of 1558 patients reported no effect on mortality. One study with a total of 2440 patients reported preoperative PH as the risk factor for increased mortality in the presence of moderate or severe PPM. Three studies evaluated the effect of PPM on postoperative PH and reported that PPM was associated with significantly increased postoperative PH. The majority of the studies reported that PPM was associated with higher peak or mean transmitral gradient and systolic pulmonary artery pressure. The results presented in these studies suggest that PPM in patients undergoing mitral valve replacement was associated with increased postoperative mean and peak transmitral gradient and higher postoperative systolic pulmonary artery pressure. PPM may be associated with increased long-term mortality. Severe PPM was directly associated with increased long-term mortality when compared with moderate or no PPM. Evidence suggests that PPM is associated with increased incidence of postoperative PH.
- 22 January 2018
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 26 (6) , 1027-1034
Does patient–prosthesis mismatch have a negative impact on outcomes following mitral valve replacement?
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether patient-prosthesis mismatch (PPM) has a negative impact on patients undergoing mitral valve replacement in terms of postoperative mortality, incidence of postoperative pulmonary hypertension (PH) and higher transmitral gradients. Altogether 103 papers were found using the reported search, 18 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Overall, 8 studies with a total of 4812 patients reported that PPM has a significantly negative impact on long-term mortality, whereas 5 studies with a total of 1558 patients reported no effect on mortality. One study with a total of 2440 patients reported preoperative PH as the risk factor for increased mortality in the presence of moderate or severe PPM. Three studies evaluated the effect of PPM on postoperative PH and reported that PPM was associated with significantly increased postoperative PH. The majority of the studies reported that PPM was associated with higher peak or mean transmitral gradient and systolic pulmonary artery pressure. The results presented in these studies suggest that PPM in patients undergoing mitral valve replacement was associated with increased postoperative mean and peak transmitral gradient and higher postoperative systolic pulmonary artery pressure. PPM may be associated with increased long-term mortality. Severe PPM was directly associated with increased long-term mortality when compared with moderate or no PPM. Evidence suggests that PPM is associated with increased incidence of postoperative PH.
- Open Access
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 15 (2) , 102-106
Conversion to thoracotomy of video-assisted thoracoscopic closure of patent ductus arteriosus
Introduction Posterolateral thoracotomy was the access of choice in surgical treatment of patent ductus arteriosus (PDA) for many years before the introduction of video-assisted thoracoscopic surgery (VATS). The latter is thought to reduce postoperative pain and improve musculoskeletal system...
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 15 (2) , 102-106
Open AccessConversion to thoracotomy of video-assisted thoracoscopic closure of patent ductus arteriosus
Introduction Posterolateral thoracotomy was the access of choice in surgical treatment of patent ductus arteriosus (PDA) for many years before the introduction of video-assisted thoracoscopic surgery (VATS). The latter is thought to reduce postoperative pain and improve musculoskeletal system...
- 3 December 2017
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 32 (12) , 758-774
The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis
Background Despite the fact that aspirin is of benefit to patients following coronary artery bypass grafting (CABG), continuation or administration of preoperative aspirin before CABG or any cardiac surgical procedure remains controversial. Therefore, we performed a systematic review and meta‐analysis to assess the influence of preoperative aspirin administration on patients undergoing cardiac surgery. Materials and Methods Medline database was searched using OVID SP interface. Similar searches were performed separately in EMBASE, PubMed, and Cochrane Central Registry of Controlled Trials. Results Twelve randomized controlled trials and 28 observational studies met our inclusion criteria and were included in the meta‐analysis. The use of preoperative aspirin in patients undergoing CABG at any dose is associated with reduced early mortality as well as a reduced incidence of postoperative acute kidney injury (AKI). Low‐dose aspirin (≤160 mg/d) is associated with a decreased incidence of perioperative myocardial infarction (MI). Administration of preoperative aspirin at any dose in patients undergoing cardiac surgery increases postoperative bleeding. Despite this effect of preoperative aspirin, it did not increase the rates of surgical re‐exploration due to excessive postoperative bleeding nor did it increase the rates of packed red blood cell transfusions (PRBC) when preoperative low‐dose aspirin (≤160 mg/d) was administered. Conclusions Preoperative aspirin increases the risk for postoperative bleeding. However, this did not result in an increased need for chest re‐exploration and did not increase the rates of PRBC transfusion when preoperative low‐dose (≤160 mg/d) aspirin was administered. Aspirin at any dose is associated with decreased mortality and AKI and low‐dose aspirin (≤160 mg/d) decreases the incidence of perioperative MI.
- 3 December 2017
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 32 (12) , 758-774
The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis
Background Despite the fact that aspirin is of benefit to patients following coronary artery bypass grafting (CABG), continuation or administration of preoperative aspirin before CABG or any cardiac surgical procedure remains controversial. Therefore, we performed a systematic review and meta‐analysis to assess the influence of preoperative aspirin administration on patients undergoing cardiac surgery. Materials and Methods Medline database was searched using OVID SP interface. Similar searches were performed separately in EMBASE, PubMed, and Cochrane Central Registry of Controlled Trials. Results Twelve randomized controlled trials and 28 observational studies met our inclusion criteria and were included in the meta‐analysis. The use of preoperative aspirin in patients undergoing CABG at any dose is associated with reduced early mortality as well as a reduced incidence of postoperative acute kidney injury (AKI). Low‐dose aspirin (≤160 mg/d) is associated with a decreased incidence of perioperative myocardial infarction (MI). Administration of preoperative aspirin at any dose in patients undergoing cardiac surgery increases postoperative bleeding. Despite this effect of preoperative aspirin, it did not increase the rates of surgical re‐exploration due to excessive postoperative bleeding nor did it increase the rates of packed red blood cell transfusions (PRBC) when preoperative low‐dose aspirin (≤160 mg/d) was administered. Conclusions Preoperative aspirin increases the risk for postoperative bleeding. However, this did not result in an increased need for chest re‐exploration and did not increase the rates of PRBC transfusion when preoperative low‐dose (≤160 mg/d) aspirin was administered. Aspirin at any dose is associated with decreased mortality and AKI and low‐dose aspirin (≤160 mg/d) decreases the incidence of perioperative MI.
- 1 February 2017
- Published by Elsevier in Journal of Surgical Research
- Vol. 208, 1-9
Minimally invasive thoracoscopic closure versus thoracotomy in children with patent ductus arteriosus
- 1 February 2017
- Published by Elsevier in Journal of Surgical Research
- Vol. 208, 1-9
Minimally invasive thoracoscopic closure versus thoracotomy in children with patent ductus arteriosus
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 1 (1) , 47-49
Thromboembolic complications after an ankle joint open fracture in a patient with a history of deep vein thrombosis in the lower limbs
A 55-year-old patient was admitted to the Department of Orthopedics due to an open fracture in the right ankle joint. On the seventh day of hospitalization the patient experienced a transient ischemic attack. During the next day, dyspnea, chest pain and a ‘rider’ type pulmonary embolism in...
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 1 (1) , 47-49
Open AccessThromboembolic complications after an ankle joint open fracture in a patient with a history of deep vein thrombosis in the lower limbs
A 55-year-old patient was admitted to the Department of Orthopedics due to an open fracture in the right ankle joint. On the seventh day of hospitalization the patient experienced a transient ischemic attack. During the next day, dyspnea, chest pain and a ‘rider’ type pulmonary embolism in...
- Open Access
- 4 October 2016
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 24 (2) , ivw317-285
What is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting?: Table 1:
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether continuation of administration of preoperative aspirin until the day of coronary artery bypass grafting (CABG) could minimize postoperative mortality, prevalence of postoperative myocardial infarction (MI) with or without influence on postoperative bleeding, packed red blood cell (PRBC) transfusion and reoperation for bleeding. Altogether, 662 papers were found using the reported search, 7 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Seven studies, included in this review, consisted of five meta-analyses and two randomized controlled trials. One meta-analysis, involving 27 533 patients submitted to CABG, showed that the administration of preoperative aspirin decreased postoperative 30-day mortality by 27%. Another meta-analysis, including 1437 patients, showed that preoperative aspirin decreased the incidence of perioperative MI by 44%, the effect being even more pronounced with low-dose aspirin, which reduced the prevalence of perioperative MI by 63%. One RCT showed that preoperative aspirin is associated with reduced long-term hazard of MI or repeated revascularization. Four meta-analyses and two RCTs showed that preoperative aspirin is associated with increased postoperative bleeding, PRBC transfusion and reoperation for bleeding. However, this was not the case with preoperative administration of low-dose aspirin. The results presented in these studies suggest that preoperative aspirin administration in patients undergoing CABG has a significant benefit in reducing the incidence of perioperative MI and 30-day mortality rate, as well as reduced long-term hazard of MI or repeated revascularization. At a higher dose (>100 mg/day), postoperative bleeding, PRBC transfusion and reoperation for bleeding increased. However, with low-dose aspirin (≤100 mg/day), these benefits were not at the expense of increased postoperative bleeding or transfusion.
- 4 October 2016
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 24 (2) , ivw317-285
Open AccessWhat is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting?: Table 1:
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether continuation of administration of preoperative aspirin until the day of coronary artery bypass grafting (CABG) could minimize postoperative mortality, prevalence of postoperative myocardial infarction (MI) with or without influence on postoperative bleeding, packed red blood cell (PRBC) transfusion and reoperation for bleeding. Altogether, 662 papers were found using the reported search, 7 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Seven studies, included in this review, consisted of five meta-analyses and two randomized controlled trials. One meta-analysis, involving 27 533 patients submitted to CABG, showed that the administration of preoperative aspirin decreased postoperative 30-day mortality by 27%. Another meta-analysis, including 1437 patients, showed that preoperative aspirin decreased the incidence of perioperative MI by 44%, the effect being even more pronounced with low-dose aspirin, which reduced the prevalence of perioperative MI by 63%. One RCT showed that preoperative aspirin is associated with reduced long-term hazard of MI or repeated revascularization. Four meta-analyses and two RCTs showed that preoperative aspirin is associated with increased postoperative bleeding, PRBC transfusion and reoperation for bleeding. However, this was not the case with preoperative administration of low-dose aspirin. The results presented in these studies suggest that preoperative aspirin administration in patients undergoing CABG has a significant benefit in reducing the incidence of perioperative MI and 30-day mortality rate, as well as reduced long-term hazard of MI or repeated revascularization. At a higher dose (>100 mg/day), postoperative bleeding, PRBC transfusion and reoperation for bleeding increased. However, with low-dose aspirin (≤100 mg/day), these benefits were not at the expense of increased postoperative bleeding or transfusion.
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 2 (2) , 135-139
Combined mitral valve replacement associated with the Bentall procedure, diaphragmatic hernia repair and reconstruction of the pectus excavatum in a 26-year-old patient with Marfan syndrome
A 26-year-old man with Marfan syndrome was admitted as an emergency patient with ascending aorta aneurysm, severe mitral and aortic regurgitation, diaphragmatic hernia and pectus excavatum. After completion of diagnostics a combined surgical procedure was performed.
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 2 (2) , 135-139
Open AccessCombined mitral valve replacement associated with the Bentall procedure, diaphragmatic hernia repair and reconstruction of the pectus excavatum in a 26-year-old patient with Marfan syndrome
A 26-year-old man with Marfan syndrome was admitted as an emergency patient with ascending aorta aneurysm, severe mitral and aortic regurgitation, diaphragmatic hernia and pectus excavatum. After completion of diagnostics a combined surgical procedure was performed.